Legislators
Bills
Statements
Lobbying
Travel
- Bills
- S.977
S.977: Transparent Drug Pricing Act of 2019
About This Bill
- This bill was introduced in the 116th Congress
- This bill is primarily about health
- Introduced April 1, 2019
- Latest Major Action April 1, 2019
Bill Sponsor
Bill Cosponsor
Bill Version
- Introduced in Senate - April 1, 2019
Bill Summary
Transparent Drug Pricing Act of 2019 This bill establishes several requirements relating to the prices of prescription drugs. For example, state Medicaid drug-use review programs must require pharmacists to disclose an individual's out-of-pocket cost for a prescription drug, and the price without health insurance, at the point-of-sale. Additionally, health insurers must publish the co-payment amount for each covered prescription drug prior to...
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
April 1, 2019 |
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
April 1, 2019 |
Introduced in the Senate by Rick Scott (R-Fla.) |